Activation of 5-HT1A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease

Neuropharmacology

Volumn 95, Issue , 2015, Pages 181-191

  Sun, Yi Na ^a   Wang, Tao ^a   Wang, Yong ^a   Han, Ling Na ^a   Li, Li Bo ^a   Zhang, Yu Ming ^a   Liu, Jian ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

5 HT1A receptor; Anxiety; Central nucleus of the amygdala; GABAergic neurons; In vivo electrophysiology; Parkinson's disease

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 AMINOBUTYRIC ACID; DOPAMINE; MONOAMINE; SEROTONIN 1A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; ANXIOLYTIC AGENT; N-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-N-(2-PYRIDINYL)CYCLOHEXANECARBOXAMIDE; OXIDOPAMINE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 AGONIST; SEROTONIN 1 ANTAGONIST;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN DAMAGE; CENTRAL NUCLEUS OF THE AMYGDALA; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; GABAERGIC SYSTEM; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; MEDIAL FOREBRAIN BUNDLE; NERVE CELL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; ACTION POTENTIAL; ANIMAL; ANXIETY DISORDERS; CENTRAL NUCLEUS (AMYGDALA); DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; PARKINSONISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACTION POTENTIALS; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; CENTRAL AMYGDALOID NUCLEUS; DOPAMINE; GABAERGIC NEURONS; LIMBIC SYSTEM; MALE; MEDIAL FOREBRAIN BUNDLE; MOTOR ACTIVITY; OXIDOPAMINE; PARKINSONIAN DISORDERS; PIPERAZINES; PYRIDINES; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS;

EID: 84925864659     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.03.007     Document Type: Article

References (74)

1. E.A. Anderzhanova, H. Bachli, O.A. Buneeva, V.B. Narkevich, A.E. Medvedev, C.K. Thoeringer, C.T. Wotjak, and V.S. Kudrin Strain differences in profiles of dopaminergic neurotransmission in the prefrontal cortex of the BALB/C vs. C57Bl/6 mice: consequences of stress and afobazole Eur. J. Pharmacol. 708 2013 95 104
2. R. Araneda, and R. Andrade 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex Neuroscience 40 1991 399 412
3. G. Aston-Jones, C. Chiang, and T. Alexinsky Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance Prog. Brain Res. 88 1991 501 520
4. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152
5. M.D. Bauman, and D.G. Amaral The distribution of serotonergic fibers in the macaque monkey amygdala: an immunohistochemical study using antisera to 5-hydroxytryptamine Neuroscience 136 2005 193 203
6. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia Neuropsychopharmacology 15 1996 442 455
7. F.J. Carod-Artal, S. Ziomkowski, H. Mourao Mesquita, and P. Martinez-Martin Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease Park. Relat. Disord. 14 2008 102 108
8. V. Carola, F. D'Olimpio, E. Brunamonti, F. Mangia, and P. Renzi Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice Behav. Brain Res. 134 2002 49 57
9. M.C. Carvalho, C.M. Moreira, J.M. Zanoveli, and M.L. Brandao Central, but not basolateral, amygdala involvement in the anxiolytic-like effects of midazolam in rats in the elevated plus maze J. Psychopharmacol. 26 2012 543 554
10. M.M. Carvalho, F.L. Campos, B. Coimbra, J.M. Pego, C. Rodrigues, R. Lima, A.J. Rodrigues, N. Sousa, and A.J. Salgado Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits Mol. Neurodegener. 8 2013 14
11. 1A binding in rat brain - a combined in situ hybridisation/in vitro receptor autoradiographic study Brain Res. 561 1991 51 60
12. 2A receptors are increased in Parkinson's disease neocortex Ann. N. Y. Acad. Sci. 861 1998 288 289
13. R. Corradetti, P.E. Le, N. Laaris, M. Hamon, and L. Lanfumey Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro J. Pharmacol. Exp. Ther. 278 1996 679 688
14. C. Delaville, J. Chetrit, K. Abdallah, S. Morin, L. Cardoit, P. De Deurwaerdere, and A. Benazzouz Emerging dysfunctions consequent to combined monoaminergic depletions in Parkinsonism Neurobiol. Dis. 45 2012 763 773
15. 1A receptors and SERT Philos. Trans. R. Soc. Lond. B Biol. Sci. 367 2012 2416 2425
16. R. Deumens, A. Blokland, and J. Prickaerts Modeling Parkinson's disease in rats: an evaluation of 6-OHDA-lesions of the nigrostriatal pathway Exp. Neurol. 175 2002 303 317
17. K.L. Eskow Jaunarajs, K.B. Dupre, C.Y. Ostock, T. Button, T. Deak, and C. Bishop Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat Behav. Pharmacol. 21 2010 627 637
18. A. Etkin, K.E. Prater, A.F. Schatzberg, V. Menon, and M.D. Greicius Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder Arch. Gen. Psychiatry 66 2009 1361 1372
19. M. Fedrowitz, S. Lindemann, W. Loscher, and M. Gernert Altered spontaneous discharge rate and pattern of basal ganglia output neurons in the circling (ci2) rat mutant Neuroscience 118 2003 867 878
20. D. Frechilla, A. Cobreros, L. Saldise, R. Moratalla, R. Insausti, M. Luquin, and J. Del Rio Serotonin 5-HT(1A) receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys Synapse 39 2001 288 296
21. F.G. Graeff, M.C. Silveira, R.L. Nogueira, E.A. Audi, and R.M. Oliveira Role of the amygdala and periaqueductal gray in anxiety and panic Behav. Brain Res. 58 1993 123 131
22. 1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze Brain Res. 732 1996 145 153
23. S.L. Handley, and J.W. McBlane Serotonin mechanisms in animal models of anxiety Braz. J. Med. Biol. Res. 26 1993 1 13
24. 1A receptor mutant mice Proc. Natl. Acad. Sci. U. S. A. 95 1998 15049 15054
25. A. Holmes, S. Parmigiani, P.F. Ferrari, P. Palanza, and R.J. Rodgers Behavioral profile of wild mice in the elevated plus-maze test for anxiety Physiol. Behav. 71 2000 509 516
26. C. Hou, L. Xue, J. Feng, L. Zhang, Y. Wang, L. Chen, T. Wang, Q.J. Zhang, and J. Liu Unilateral lesion of the nigrostriatal pathway decreases the response of GABA interneurons in the dorsal raphe nucleus to 5-HT(1A) receptor stimulation in the rat Neurochem. Int. 61 2012 1344 1356
27. 1A receptor activation in the hemiparkinsonian rat Behav. Brain Res. 277 2014 211 220
28. P. Huot, S.H. Fox, and J.M. Brotchie The serotonergic system in Parkinson's disease Prog. Neurobiol. 95 2011 163 212
29. 2A receptor-mediated serotonergic facilitation of GABA release in juvenile rat basolateral amygdala Neuropsychopharmacology 34 2009 410 423
30. J. Jungnickel, I. Kalve, L. Reimers, A. Nobre, M. Wesemann, A. Ratzka, N. Halfer, C. Lindemann, K. Schwabe, K. Tollner, M. Gernert, and C. Grothe Topology of intrastriatal dopaminergic grafts determines functional and emotional outcome in neurotoxin-lesioned rats Behav. Brain Res. 216 2011 129 135
31. N.H. Kalin, S.E. Shelton, and R.J. Davidson The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate J. Neurosci. 24 2004 5506 5515
32. M.H. Kang-Park, W.A. Wilson, and S.D. Moore Differential actions of diazepam and zolpidem in basolateral and central amygdala nuclei Neuropharmacology 46 2004 1 9
33. H. Kawahara, Y. Kawahara, and B.H. Westerink The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of noradrenaline in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain Eur. J. Pharmacol. 387 2000 279 286
34. I.C. Kilpatrick, M.W. Jones, and O.T. Phillipson A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation J. Neurochem. 46 1986 1865 1876
35. Y. Kitaichi, T. Inoue, S. Nakagawa, Y. Omiya, N. Song, Y. An, C. Chen, I. Kusumi, and T. Koyama Local infusion of citalopram into the basolateral amygdala decreased conditioned fear of rats through increasing extracellular serotonin levels Prog. Neuropsychopharmacol. Biol. Psychiatry 54 2014 216 222
36. J.E. Krettek, and J.L. Price Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat J. Comp. Neurol. 178 1978 225 254
37. 1A receptors in rat brain: lack of effect of repeated injections of fluoxetine Brain Res. 769 1997 141 151
38. 1A) in 5-HT transporter knock-out mice: gender and brain region differences J. Neurosci. 20 2000 7888 7895
39. L. Marsh Neuropsychiatric aspects of Parkinson's disease Psychosomatics 41 2000 15 23
40. I.D. Martijena, C. Lacerra, and V.A. Molina Carbamazepine normalizes the altered behavioral and neurochemical response to stress in benzodiazepine-withdrawn rats Eur. J. Pharmacol. 330 1997 101 108
41. L.P. Martin, D.M. Jackson, C. Wallsten, and B.L. Waszczak Electrophysiological comparison of 5-hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing J. Pharmacol. Exp. Ther. 288 1999 820 826
42. M. Martina, S. Royer, and D. Pare Physiological properties of central medial and central lateral amygdala neurons J. Neurophysiol. 82 1999 1843 1854
43. A.J. McDonald Cytoarchitecture of the central amygdaloid nucleus of the rat J. Comp. Neurol. 208 1982 401 418
44. M.J. Millan The neurobiology and control of anxious states Prog. Neurobiol. 70 2003 83 244
45. R.Y. Moore, A.E. Halaris, and B.E. Jones Serotonin neurons of the midbrain raphe: ascending projections J. Comp. Neurol. 180 1978 417 438
46. 1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus Neuropharmacology 33 1994 61 66
47. I. Muraki Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate Hokkaido. Igaku. Zasshi 76 2001 57 70
48. D. Pare, Y. Smith, and J.F. Pare Intra-amygdaloid projections of the basolateral and basomedial nuclei in the cat: Phaseolus vulgaris-leucoagglutinin anterograde tracing at the light and electron microscopic level Neuroscience 69 1995 567 583
49. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates fourth ed. 1998 Academic Press New York
50. A. Pitkanen, V. Savander, and J.E. LeDoux Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala Trends Neurosci. 20 1997 517 523
51. A. Pitkanen Connectivity of the rat amygdaloid complex J.P. Aggleton, The Amygdala: a Functional Analysis 2000 Oxford University Press Oxford 31 115
52. R.D. Prediger, F.C. Matheus, M.L. Schwarzbold, M.M. Lima, and M.A. Vital Anxiety in Parkinson's disease: a critical review of experimental and clinical studies Neuropharmacology 62 2012 115 124
53. M.E. Pum, J.P. Huston, and C.P. Muller The role of cortical serotonin in anxiety and locomotor activity in Wistar rats Behav. Neurosci. 123 2009 449 454
54. K.J. Ressler, and C.B. Nemeroff Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders Depress. Anxiety 12 Suppl. 1 2000 2 19
55. T.A. Retson, and E.J. Van Bockstaele Coordinate regulation of noradrenergic and serotonergic brain regions by amygdalar neurons J. Chem. Neuroanat. 52 2013 9 19
56. T.A. Rizvi, M. Ennis, M.M. Behbehani, and M.T. Shipley Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: topography and reciprocity J. Comp. Neurol. 303 1991 121 131
57. A.F. Sadikot, and A. Parent The monoaminergic innervation of the amygdala in the squirrel monkey: an immunohistochemical study Neuroscience 36 1990 431 447
58. P. Sah, E.S. Faber, M. Lopez De Armentia, and J. Power The amygdaloid complex: anatomy and physiology Physiol. Rev. 83 2003 803 834
59. V. Savander, C.G. Go, J.E. LeDoux, and A. Pitkanen Intrinsic connections of the rat amygdaloid complex: projections originating in the basal nucleus J. Comp. Neurol. 361 1995 345 368
60. V. Savander, C.G. Go, J.E. Ledoux, and A. Pitkanen Intrinsic connections of the rat amygdaloid complex: projections originating in the accessory basal nucleus J. Comp. Neurol. 374 1996 291 313
61. A.M. Schneider, E. Wilkins, A. Firestone, E.C. Everbach, J.C. Naylor, and P.E. Simson Enhanced retention in the passive-avoidance task by 5-HT(1A) receptor blockade is not associated with increased activity of the central nucleus of the amygdala Learn. Mem. 10 2003 394 400
62. B. Scholtissen, F.R. Verhey, H.W. Steinbusch, and A.F. Leentjens Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data J. Neural. Transm. 113 2006 59 73
63. M. Shiba, J.H. Bower, D.M. Maraganore, S.K. McDonnell, B.J. Peterson, J.E. Ahlskog, D.J. Schaid, and W.A. Rocca Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study Mov. Disord. 15 2000 669 677
64. L.M. Shulman, R.L. Taback, J. Bean, and W.J. Weiner Comorbidity of the nonmotor symptoms of Parkinson's disease Mov. Disord. 16 2001 507 510
65. N. Sousa, O.F. Almeida, and C.T. Wotjak A hitchhiker's guide to behavioral analysis in laboratory rodents Genes. Brain Behav. 5 Suppl. 2 2006 5 24
66. 1B agonists Synapse 1 1987 3 9
67. N. Sun, and M.D. Cassell Intrinsic GABAergic neurons in the rat central extended amygdala J. Comp. Neurol. 330 1993 381 404
68. 2A/2C receptor activation is decreased in rats with 6-hydroxydopamine lesions Neuropharmacology 73 2013 404 414
69. C.M. Thiel, and R.K. Schwarting Dopaminergic lateralisation in the forebrain: relations to behavioural asymmetries and anxiety in male Wistar rats Neuropsychobiology 43 2001 192 199
70. K.M. Tye, R. Prakash, S.Y. Kim, L.E. Fenno, L. Grosenick, H. Zarabi, K.R. Thompson, V. Gradinaru, C. Ramakrishnan, and K. Deisseroth Amygdala circuitry mediating reversible and bidirectional control of anxiety Nature 471 2011 358 362
71. P. Veinante, and M.J. Freund-Mercier Intrinsic and extrinsic connections of the rat central extended amygdala: an in vivo electrophysiological study of the central amygdaloid nucleus Brain Res. 794 1998 188 198
72. S. Wang, Q.J. Zhang, J. Liu, Z.H. Wu, U. Ali, Y. Wang, L. Chen, and Z.H. Gui The firing activity of pyramidal neurons in medial prefrontal cortex and their response to 5-hydroxytryptamine-1A receptor stimulation in a rat model of Parkinson's disease Neuroscience 162 2009 1091 1100
73. M.J. Watt, A.R. Burke, K.J. Renner, and G.L. Forster Adolescent male rats exposed to social defeat exhibit altered anxiety behavior and limbic monoamines as adults Behav. Neurosci. 123 2009 564 576
74. D.E. Wright, K.B. Seroogy, K.H. Lundgren, B.M. Davis, and L. Jennes Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain J. Comp. Neurol. 351 1995 357 373